THE PERFORMANCE OF HE4 BIOMARKER IN PREDICTION OF MALIGNANCY IN  OVARIAN MASS

Dr. Sushma Rachel S, Dr. Nagarathna Gopala, Dr. Rohanchandra R Gatty

THE PERFORMANCE OF HE4 BIOMARKER IN PREDICTION OF MALIGNANCY IN OVARIAN MASS

Authors

Dr. Sushma Rachel S, Dr. Nagarathna Gopala, Dr. Rohanchandra R Gatty

Keywords:

Ovarian cancer, CA125, HE4

Abstract

ABSTRACT: In India, ovarian cancer is the third leading cause of cancer deaths in women after cervicaland breast cancer. The high mortality of ovarian cancer is attributed mainly to late diagnosis. The poorlong term survival rates are mostly due to presentation of patients in advanced stages.

References

Basu P, De P, Mandal S, Ray K, Biswas J. Study of'patterns of care'of ovarian cancer patients in a specialized cancer institute in Kolkata, eastern India. Indian journal of cancer. 2009 Jan 1;46(1):28.

Downloads

Published

2025-10-17

How to Cite

Dr. Sushma Rachel S, Dr. Nagarathna Gopala, Dr. Rohanchandra R Gatty. (2025). THE PERFORMANCE OF HE4 BIOMARKER IN PREDICTION OF MALIGNANCY IN OVARIAN MASS . International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 2513–2520. Retrieved from https://www.ijprt.org/index.php/pub/article/view/1082